Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

ADIR describes new PDE IV-inhibitory flavones

June 17, 1998

Biogen seeks partners to continue development of gelsolin

June 16, 1998

New antiallergic and antiinflammatory compounds developed by Astra researchers

June 11, 1998

tgAAV-CFTR research results published in The Lancet

June 11, 1998

Pfizer discloses indazole inhibitors of PDE and TNF production

June 11, 1998

Byk Gulden patents another series of thiazole PDE IV inhibitors

June 9, 1998

Genome Therapeutics reaches milestone in Schering-Plough alliance

June 9, 1998

Bronchotherapeutic agents in development at Byk Gulden

June 8, 1998

Clinical protocol for phase I/II testing of tgAAV-CFTR

June 5, 1998

Zyrtec approved for use in children as young as two years

June 5, 1998

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...